[{"innerBlocks":[],"name":"core\/freeform","postId":2926,"blockType":{"name":"core\/freeform","keywords":[],"attributes":{"content":{"type":"string","source":"raw"},"lock":{"type":"object"}},"providesContext":[],"usesContext":[],"selectors":[],"supports":{"className":false,"customClassName":false,"reusable":false},"styles":[],"variations":[],"apiVersion":3,"title":"Classic","description":"Use the classic WordPress editor.","category":"text"},"originalContent":"Long time healthcare investors Todd Cozzens and Jared Kesselheim, MD, have launched Leerink Transformation Fund with a focus exclusively on healthcare information technology and related services, anticipating investing as much as $340 million in emerging companies.

\u201cWe are distinctly positioned to help the best healthcare IT and services companies, and their leaders, accelerate their growth because of our differential backgrounds as founders, operators, clinicians and investors,\u201d says Cozzens.

Also See:<\/b> Investments in augmented and virtual reality skyrocketing<\/a>

To start, the new fund made investment in six IT and services companies:

\u2022\tOutcome Health, which offers technology that provides health intelligence at the point of care.

\u2022\tScientist.com, which aims to shorten pharmaceutical research and development cycles.

\u2022\tVera Whole Health, which offers employer-based onsite primary care.

\u2022\tPatientPing, a service that enables real-time admission and discharge notifications.

\u2022\tHealth Catalyst, a company that specializes in healthcare analytics.

\u2022\tKyruus, which has technology that matches patients with the right provider.

The investors built the fund entirely with a focus on healthcare IT and services to take advantage of the rapid adoption of heath IT under the HITECH Act, coupled with an ongoing reimbursement shift away from fee-for-service and toward value-based care, Kesselheim says.

\u201cThese drivers have created an unprecedented opportunity for disruption in a massive market whose complexity is best addressed by a fund with a 100 percent sector focus,\u201d he adds.

The fund launched with assistance from LEERINK, a healthcare investment bank offering equity research, merger and acquisition advisory services and investment banking.

Also created was MEDACorp., a network for physicians, regulatory and reimbursement specialists, hospital and insurer business managers and researchers, with the intent of aiding healthcare professionals in assessing merger and acquisition deals. More information is available here<\/a>.
","saveContent":"Long time healthcare investors Todd Cozzens and Jared Kesselheim, MD, have launched Leerink Transformation Fund with a focus exclusively on healthcare information technology and related services, anticipating investing as much as $340 million in emerging companies.

\u201cWe are distinctly positioned to help the best healthcare IT and services companies, and their leaders, accelerate their growth because of our differential backgrounds as founders, operators, clinicians and investors,\u201d says Cozzens.

Also See:<\/b> Investments in augmented and virtual reality skyrocketing<\/a>

To start, the new fund made investment in six IT and services companies:

\u2022\tOutcome Health, which offers technology that provides health intelligence at the point of care.

\u2022\tScientist.com, which aims to shorten pharmaceutical research and development cycles.

\u2022\tVera Whole Health, which offers employer-based onsite primary care.

\u2022\tPatientPing, a service that enables real-time admission and discharge notifications.

\u2022\tHealth Catalyst, a company that specializes in healthcare analytics.

\u2022\tKyruus, which has technology that matches patients with the right provider.

The investors built the fund entirely with a focus on healthcare IT and services to take advantage of the rapid adoption of heath IT under the HITECH Act, coupled with an ongoing reimbursement shift away from fee-for-service and toward value-based care, Kesselheim says.

\u201cThese drivers have created an unprecedented opportunity for disruption in a massive market whose complexity is best addressed by a fund with a 100 percent sector focus,\u201d he adds.

The fund launched with assistance from LEERINK, a healthcare investment bank offering equity research, merger and acquisition advisory services and investment banking.

Also created was MEDACorp., a network for physicians, regulatory and reimbursement specialists, hospital and insurer business managers and researchers, with the intent of aiding healthcare professionals in assessing merger and acquisition deals. More information is available here<\/a>.
","order":0,"get_parent":{},"attributes":[],"attributesType":{"content":{"type":"string","source":"raw"},"lock":{"type":"object"}},"dynamicContent":""}]

New investment firm targets dollars for healthcare IT

More for you